Journal of Osteopathic Medicine, 2026/01, 126(1):11–14. doi: 10.1515/jom-2025-0039, type of study: article

Free full text   (https://www.degruyterbrill.com/document/doi/10.1515/jom-2025-0039/html)

Keywords:

article [2635]
economics [58]
legislation [13]
private equity [1]
USA [1752]

Abstract:

Private equity (PE) involvement in healthcare has generated considerable debate regarding its implications for patient care, healthcare quality, and system sustainability. While PE can inject much-needed capital into struggling healthcare facilities, its profit-driven motives and focus on short-term financial gains can lead to cost-cutting measures and business closures that jeopardize patient access and the quality of care. To maximize profits, PE firms may exploit legal and regulatory loopholes, engage in aggressive billing practices, and acquire healthcare providers to reduce competition through consolidation, driving up prices. Evidence suggests that there are both risks and benefits to PE involvement in healthcare, with some studies reporting increased costs and quality concerns, whereas others highlight improved operational efficiency and stabilization of at-risk providers. This commentary provides an overview of both sides and offers policy recommendations addressing some of the detrimental effects of PE practices on the healthcare sector, to ensure that patient well-being remains the priority.